600056 中国医药
2024/06 - 中期
人民币(K¥)
与去年末期
比较
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
2020/12
人民幣(K¥)

非流动资产
长期股权投资2,672,2770.87%2,649,1272,570,6142,464,2992,350,357
投资性房地产87,802-2.26%89,83396,604103,968103,403
固定资产2,273,544-1.81%2,315,5062,340,4102,214,9671,499,903
在建工程202,9713.54%196,023201,196418,185964,565
无形资产607,4060.52%604,266485,673425,452375,560
商誉1,123,8220.00%1,123,8221,123,8221,312,8591,380,355
其他非流动资产1,959,7512.87%1,905,1522,146,5351,981,7241,454,706
8,927,5730.49%8,883,7298,964,8548,921,4558,128,850

流动资产
货币资金3,209,713-17.00%3,867,2664,260,3472,798,9313,554,982
应收账款15,478,30811.85%13,838,23713,153,67311,165,82311,140,112
存货5,884,058-5.59%6,232,2636,083,4125,656,7416,849,134
其他流动资产4,119,744-10.21%4,588,4163,437,0762,567,6003,518,958
28,691,8230.58%28,526,18326,934,50822,189,09525,063,187

流动负债
短期借款3,315,45547.35%2,250,023997,6391,490,2562,607,012
应付票据1,219,357-8.77%1,336,5881,186,5891,065,9601,241,823
应付帐款8,573,6970.19%8,557,3057,584,0415,438,3525,539,163
其他流动负债6,184,2915.55%5,859,3868,244,4765,502,5077,744,564
19,292,8007.16%18,003,30218,012,74513,497,07517,132,563
流动资产净值9,399,022-10.68%10,522,8818,921,7638,692,0197,930,624
资产总额减流动负债18,326,596-5.57%19,406,61017,886,61717,613,47416,059,473

非流动负债
长期借款1,928,357-23.12%2,508,3672,250,0002,982,0001,880,289
应付债券0--0000
其他非流动负债2,429,493-19.30%3,010,6182,465,9632,122,0151,960,826
4,357,850-21.04%5,518,9854,715,9635,104,0153,841,115

总权益
    实收股本1,495,8800.00%1,495,8801,495,8801,068,4861,068,486
    储备项目10,073,9110.09%10,064,6689,318,5839,189,5188,936,807
股东权益11,569,7910.08%11,560,54810,814,46310,258,00310,005,293
非控股权益2,398,9553.09%2,327,0772,356,1912,251,4552,213,065